SCHEMBL6949967

SCHEMBL6949967

COc1ncnc(N2CCc3ccccc3CC2)c1[N+](=O)[O-]

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
ACHE P22303 2/20 0.43
BACE1 P56817 2/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
GPR119 Q8TDV5 7/20 0.42
RPS6KB1 P23443 2/20 0.41
MAPT P10636 3/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
KDM4E B2RXH2 2/20 0.40
MAPK1 P28482 2/20 0.40
NPSR1 Q6W5P4 1/20 0.39
MGMT P16455 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6957529 0.85 HRH4 (0.48) HTTSMN1; SMN2NPC1RAB9AGPR119
SCHEMBL6951809 0.81 MEN1 (0.40) HTTSMN1; SMN2MEN1KMT2ANPC1
SCHEMBL6947729 0.81 HTT (0.73) HTTSMN1; SMN2MEN1KMT2ANPC1
SCHEMBL6948779 0.81 HTT (0.52) HTTSMN1; SMN2MEN1KMT2ARPS6KB1
SCHEMBL6949468 0.81 HTT (0.52) HTTSMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL6949507 0.80 HTT (0.49) HTTSMN1; SMN2MEN1KMT2AGPR119
SCHEMBL6951855 0.76 ATM (0.43) HTTSMN1; SMN2MEN1KMT2AGPR119
SCHEMBL3674430 0.75 MEN1 (0.50) HTTSMN1; SMN2MEN1KMT2ANPC1
SCHEMBL14334346 0.75 HRH1 (0.44) HTTMEN1KMT2AACHEBACE1
SCHEMBL6945564 0.75 HTT (0.46) HTTSMN1; SMN2MEN1KMT2AGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed